Insights

Global Research Presence Emmes has established a strong international footprint with offices across the US, Europe, Canada, and India, enabling it to support global clinical trials and expand service offerings to multinational pharmaceutical and biotech clients.

Expanded Therapeutic Expertise With specialized knowledge in Vaccines, Infectious Diseases, Ophthalmology, Immunology, and Neuroscience, Emmes is well-positioned to attract clients working across diverse and high-growth therapeutic areas, especially in emerging fields like cell and gene therapy.

Innovative Data Capabilities Investments in advanced data management platforms, biostatistics, and bioinformatics present opportunities to offer enhanced data solutions and analytics services that meet the evolving needs of biopharmaceutical companies.

Mid-Sized Market Position With a revenue estimated between 250M to 500M and a workforce of over 1,000 professionals, Emmes offers a balanced scale that can serve mid-tier and emerging biotech firms seeking flexible, high-quality clinical research partnerships.

Aligned Values and Flexibility Emmes’s focus on integrity, collaboration, and innovation, combined with its commitment to diversity and agility, provides a compelling value proposition for clients seeking a dependable and adaptable CRO for complex and evolving clinical trial needs.

Emmes Tech Stack

Emmes uses 8 technology products and services including git, Microsoft 365, OneDrive, and more. Explore Emmes's tech stack below.

  • git
    Development
  • Microsoft 365
    Email
  • OneDrive
    File Sharing
  • Font Awesome
    Font Scripts
  • Google Cloud Platform
    Infrastructure As A Service
  • ServiceNow
    Miscellaneous
  • JavaScript
    Programming Languages
  • AWS Security Hub
    Security

Media & News

Emmes's Email Address Formats

Emmes uses at least 1 format(s):
Emmes Email FormatsExamplePercentage
FLast@emmes.comJDoe@emmes.com
90%
First.Last@emmes.comJohn.Doe@emmes.com
8%
FirstLast@emmes.comJohnDoe@emmes.com
1%
FiLast@emmes.comJoDoe@emmes.com
1%

Frequently Asked Questions

What is Emmes's stock symbol?

Minus sign iconPlus sign icon
Emmes is a publicly traded company; the company's stock symbol is EMMESSA.BO.

What is Emmes's official website and social media links?

Minus sign iconPlus sign icon
Emmes's official website is emmes.com and has social profiles on LinkedInCrunchbase.

How much revenue does Emmes generate?

Minus sign iconPlus sign icon
As of December 2025, Emmes's annual revenue is estimated to be $5B.

What is Emmes's NAICS code?

Minus sign iconPlus sign icon
Emmes's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Emmes have currently?

Minus sign iconPlus sign icon
As of December 2025, Emmes has approximately 1.3K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer Ceo): J. B.Chief Executive Officer: P. R.Chief Executive Officer: R. L.. Explore Emmes's employee directory with LeadIQ.

What industry does Emmes belong to?

Minus sign iconPlus sign icon
Emmes operates in the Research Services industry.

What technology does Emmes use?

Minus sign iconPlus sign icon
Emmes's tech stack includes gitMicrosoft 365OneDriveFont AwesomeGoogle Cloud PlatformServiceNowJavaScriptAWS Security Hub.

What is Emmes's email format?

Minus sign iconPlus sign icon
Emmes's email format typically follows the pattern of FLast@emmes.com. Find more Emmes email formats with LeadIQ.

Emmes

Research ServicesMaryland, United States1001-5000 Employees

For over 40 years, our team of 1,000+ experienced professionals have provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines.  With offices throughout the US, Europe, Canada, and India, Emmes supports the advancement of global public health and biopharmaceutical innovation through disciplined science, rigorous research, fact-based decision-making, and operational excellence. 

Emmes possesses knowledge across a broad range of therapeutic areas, with specializations in Vaccines and Infectious Diseases, Ophthalmology, Immunology and Neuroscience.  From comprehensive support of pandemic research to groundbreaking work in cell and gene therapy across the globe, Emmes has collaborated on clinical research across a wide array of disease states in over 75 nations.  

As a strategic collaborator with applied talent in over 2,000 clinical trials and contributions to over 2,500 publications that advance the understanding of medicine and public health, Emmes is committed to expanding the services offered to best meet the changing needs of clients and studies.  Ongoing investments in global clinical research capabilities, innovative data management platforms, biostatistics/bioinformatics expertise, and people have enabled Emmes to provide a multi-faceted approach to help you meet your research objectives.

Emmes is a diverse, inclusive, innovative CRO that values integrity, agility, passion for excellence, collaborative partnerships, and intellectual curiosity.

Section iconCompany Overview

Website
emmes.com
Stock Symbol
EMMESSA.BO
NAICS Code
5417 - Scientific Research and Development Services
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $250M$500M

    Emmes's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Emmes's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.